HRP20040721A2 - Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent - Google Patents

Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent Download PDF

Info

Publication number
HRP20040721A2
HRP20040721A2 HR20040721A HRP20040721A HRP20040721A2 HR P20040721 A2 HRP20040721 A2 HR P20040721A2 HR 20040721 A HR20040721 A HR 20040721A HR P20040721 A HRP20040721 A HR P20040721A HR P20040721 A2 HRP20040721 A2 HR P20040721A2
Authority
HR
Croatia
Prior art keywords
zero
methyl
hydrogen
independently
production
Prior art date
Application number
HR20040721A
Other languages
English (en)
Croatian (hr)
Inventor
Kleemann Heinz-Werner
Below Peter
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of HRP20040721A2 publication Critical patent/HRP20040721A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/10—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20040721A 2002-02-07 2003-01-23 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent HRP20040721A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10204989A DE10204989A1 (de) 2002-02-07 2002-02-07 Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PCT/EP2003/000653 WO2003066620A1 (de) 2002-02-07 2003-01-23 Dihydro-thia-phenanthren-carbonyl-guanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum

Publications (1)

Publication Number Publication Date
HRP20040721A2 true HRP20040721A2 (en) 2005-06-30

Family

ID=27618378

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040721A HRP20040721A2 (en) 2002-02-07 2003-01-23 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent

Country Status (24)

Country Link
EP (1) EP1474414B1 (sr)
JP (1) JP4410564B2 (sr)
KR (1) KR20040096555A (sr)
CN (1) CN1319963C (sr)
AR (1) AR038393A1 (sr)
AT (1) ATE380805T1 (sr)
AU (1) AU2003208337A1 (sr)
BR (1) BR0307495A (sr)
CA (1) CA2475093A1 (sr)
CO (1) CO5601008A2 (sr)
DE (2) DE10204989A1 (sr)
HR (1) HRP20040721A2 (sr)
HU (1) HUP0402595A2 (sr)
MA (1) MA27171A1 (sr)
MX (1) MXPA04007476A (sr)
NO (1) NO20043717L (sr)
NZ (1) NZ534536A (sr)
PE (1) PE20030963A1 (sr)
PL (1) PL370271A1 (sr)
RS (1) RS69204A (sr)
RU (1) RU2306311C2 (sr)
TW (1) TWI268927B (sr)
WO (1) WO2003066620A1 (sr)
ZA (1) ZA200406015B (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200614995A (en) * 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Tricyclic guanidine derivatives as sodium-proton exchange inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60262887A (ja) * 1984-06-11 1985-12-26 Mitsubishi Chem Ind Ltd 液晶組成物
GB8505756D0 (en) * 1985-03-06 1985-04-11 Erba Farmitalia Tricyclic dibenzo condensed derivatives
US4948806A (en) * 1988-03-30 1990-08-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
DE19601303A1 (de) * 1996-01-16 1997-07-17 Boehringer Ingelheim Kg Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln
WO2000064445A1 (en) * 1999-04-23 2000-11-02 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
DE10001879A1 (de) * 2000-01-19 2001-07-19 Aventis Pharma Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
AU2003208337A1 (en) 2003-09-02
PE20030963A1 (es) 2004-01-12
BR0307495A (pt) 2004-12-28
CA2475093A1 (en) 2003-08-14
HK1073656A1 (en) 2005-10-14
RU2306311C2 (ru) 2007-09-20
TW200404792A (en) 2004-04-01
ATE380805T1 (de) 2007-12-15
CO5601008A2 (es) 2006-01-31
EP1474414A1 (de) 2004-11-10
DE50308787D1 (de) 2008-01-24
CN1630649A (zh) 2005-06-22
ZA200406015B (en) 2005-11-14
TWI268927B (en) 2006-12-21
CN1319963C (zh) 2007-06-06
PL370271A1 (en) 2005-05-16
NO20043717L (no) 2004-11-03
DE10204989A1 (de) 2003-08-21
JP2005517015A (ja) 2005-06-09
JP4410564B2 (ja) 2010-02-03
HUP0402595A2 (hu) 2005-04-28
RU2004126854A (ru) 2006-01-27
AR038393A1 (es) 2005-01-12
MXPA04007476A (es) 2004-11-10
WO2003066620A1 (de) 2003-08-14
EP1474414B1 (de) 2007-12-12
KR20040096555A (ko) 2004-11-16
MA27171A1 (fr) 2005-01-03
NZ534536A (en) 2006-02-24
RS69204A (sr) 2006-12-15

Similar Documents

Publication Publication Date Title
RU2305093C2 (ru) Фторированные циклоалкилзамещенные бензоилгуанидины, способ их получения, их применение в качестве лекарственного средства, а также содержащее их лекарственное средство
US8008352B2 (en) Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
RU2164913C2 (ru) Гуанидиды алкенилкарбоновых кислот, способ их получения, способ ингибирования клеточного na+/h+-обмена и фармацевтическая композиция
CN100506791C (zh) 五氟硫基苯甲酰基胍、其制备方法、其作为药物或诊断剂的用途以及包含它们的药物
RU2190600C2 (ru) Замещенные 2-нафтоилгуанидины и лекарственное средство на их основе
PL183629B1 (pl) Nowe podstawione pochodne benzyloksykarbonyloguanidyny, sposób ich wytwarzania oraz środek farmaceutyczny
UA77551C2 (en) Substituted thiophene derivatives, method of production, their use as drugs or diagnostic reagents, pharmaceutical compositions
RU2306311C2 (ru) Дигидротиафенантренкарбонилгуанидины, их применение в качестве лекарственного средства
US6730697B2 (en) Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid
PT810205E (pt) 1-naftoilguanidinas substituidas processo para a sua preparacao sua utilizacao como medicamento ou meio de diagnostico bem como medicamento que as contem
JP4571803B2 (ja) 置換されたイミダゾリジン、その製造方法、その医薬又は診断薬としての使用、及び、置換されたイミダゾリジンを含有する医薬
SK282351B6 (sk) Orto-substituované benzoylguanidíny, spôsob ich výroby, ich použitie ako liečiva alebo diagnostického prostriedku a liečivo, ktoré ich obsahuje
HRP980169A2 (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicaments containing them
EP1791813B1 (de) Pentafluorsulfanylphenyl-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
US20050124681A1 (en) Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20061212

Year of fee payment: 5

OBST Application withdrawn